Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-08

Clinical Trial Update: Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing high-dose acyclovir suppressive therapy to once-daily valacyclovir in adults with genital herpes; results posted after comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir (Valacyclovir)
  • acyclovir (high-dose) (acyclovir)

Snippet

Sponsor: University of Washington | Conditions: Genital Herpes | Phase 4 | Status: COMPLETED | Results posted: 2014-10-08